Supervised classification of bradykinesia for Parkinson’s disease diagnosis from smartphone videos by David C. Wong (7168235) et al.
Supervised classification of bradykinesia for Parkinson’s disease
diagnosis from smartphone videos
David C. Wong∗, Samuel D. Relton∗, Hui Fang†, Rami Qhawaji‡, Christopher D. Graham§, Jane Alty∗¶ and Stefan Williams∗¶
∗Leeds Institute of Health Sciences, Univ. of Leeds, UK
†Dept. of Computer Science, Loughborough University, UK
‡School of Electronic Engineering and Computer Science, Univ. of Bradford, UK
§School of Psychology, Queen’s University Belfast, Northern Ireland
¶Leeds Teaching Hospital NHS Trust, UK
Abstract—Slowness of movement, known as bradykinesia,
in an important early symptom of Parkinson’s disease. This
symptom is currently assessed subjectively by clinical experts.
However, expert assessment has been shown to be subject
to inter-rater variability. We propose a low-cost, contactless
system using smartphone videos to automatically determine
the presence of bradykinesia. Using 70 videos recorded in a
pilot study, we predict the presence of bradykinesia with an
estimated test accuracy of 0.79 and the presence of Parkinson’s
disease diagnosis with estimated test accuracy 0.63. Even on
a small set of pilot data this accuracy is comparable to that
recorded by blinded human experts.
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I. INTRODUCTION
Parkinson’s disease is a neurodegenerative disorder that
affects approximately 1 in 500 adults in the UK [1]. The
diagnosis is a clinical one, based on the clinician detecting
the presence of a slowness of movement termed bradyki-
nesia, together with at least one of rigidity, rest tremor or
postural instability (United Kingdom Parkinson’s Disease
Society Brain Bank Criteria) [2]–[4].
The most common method to detect bradykinesia involves
a specially trained clinician making a visual assessment of
the patient tapping finger and thumb together. In this test,
a patient is asked to tap their forefinger against their thumb
for 10 seconds (as wide and quick as possible). The clinician
observes for impairment of speed, amplitude or rhythm, and
there is often also a progressive ‘decrement’ seen over the
duration of the test [4], [5].
However, this visual clinical judgment is inherently sub-
jective, and there is no objective measure in routine clinical
use. Given both the imprecise definition of the term, and the
difficulty for human observers to quantify small differences
in movement, it is little surprise that inter-rater assessment
of bradykinesia is moderate at best [4], [5]. Current evidence
suggests that human observers prioritize changes in move-
ment amplitude over changes in the frequency or rhythm [4].
Given the importance of bradykinesia to diagnose and
monitor Parkinson’s, and the relatively small group of neu-
rologists trained to assess it, an automatic and objective
method of determining the level of bradykinesia has the po-
tential to improve early diagnosis and to standardize follow-
up assessment. Robust implementation of such a system
might also allow home-monitoring of disease progression
and richer longitudinal information to inform patient care.
Other approaches have previously been suggested for ob-
jective bradykinesia assessment [6]–[8]. However, all prior
methods either require sensors that may not be readily avail-
able, or they require the patient to interact with a specific
computer program or smartphone app. To our knowledge,
there is only one previous report that involves standard video
to objectively measure bradykinesia, but the participants all
had advanced Parkinson’s disease, and the method required
the face to be included in the video [9]. Here we propose a
solution that uses the ubiquitous smartphone video camera to
capture the relevant data during standard clinical assessment.
Our primary aim is to provide proof-of-concept that
one can automate the assessment of bradykinesia, negating
the impact of inter-rater variability and providing easily
accessible clinical decision support. We also investigate the
potential for diagnosis of Parkinson’s disease itself. We
describe how the video signal is processed and how pertinent
features may be extracted to predict both bradykinesia and
the presence of a Parkinson’s disease diagnosis. Finally, we
present initial results from a case-control pilot study.
II. EXISTING WORK
In general, three main approaches have been used to
objectively record bradykinesia on finger tapping: 1) touch
plate or computer key, 2) gyroscope and/or accelerometer,
and 3) optical tracking of infrared markers.
These methods are compared to expert classification on
one of two clinically validated scoring systems. The Uni-
versal Parkinson’s Disease Rating Scale (UPDRS) gives an
overall score from 0 (no bradykinesia) to 4 (severe bradyki-
nesia) based on the first 10 finger taps [10]. The Modified
Bradykinesia Rating Scale (MBRS) gives a separate score
from 0 (no impairment) to 4 (severe impairment) for each
of the three aspects of bradykinesia – speed, amplitude, and
rhythm [4] – based upon ten seconds of tapping.
For 33 Parkinson’s disease (PD) patients, Giovanonni et
al. found the number of keyboard finger taps in 60 seconds
was significantly lower than controls (107 vs. 182), and
correlated with clinician UPDRS rating, r = 0.69 [11].
Papapetropoulos et al. reported a modest but significant
improvement in the maximum frequency of tapping a touch
recording plate among 7 patients after deep brain stimulation
to treat PD (4Hz before, 4.6Hz after) [12]. More recently,
finger tapping within two rectangles on a smartphone screen
showed a correlation of r = 0.75 with clinical UPDRS rat-
ing, with some features predictive of PD diagnosis, e.g. area
under the curve (AUC) of 0.92 for distance of taps [13].
Gyroscope and/or accelerometer devices attached to fore-
finger and thumb provide a richer signal and can records
the standard clinical finger-thumb tap examination. An ac-
celerometer study showed that patients had higher beat decay
of the auto-mutual information value (a signal predictability
measure) vs. controls, giving a diagnostic accuracy of around
80% [14]. In 50 PD patients, Heldman et al. showed
correlations between gyroscope recording and clinical rating
for each of the three distinct components of bradykinesia
according to the MBRS [4]. Angular velocity correlated with
speed (-0.79), the excursion angle correlated with amplitude
(-0.81), and the coefficient of variation correlated with
rhythm (0.65) [4]. Furthermore, among 18 patients at each
of 10 different deep brain stimulation amplitudes, gyroscope
measurements showed higher test-retest reliability calculated
as intraclass correlation and greater sensitivity calculated as
minimal detectable change [15].
Using 3D recording of infrared markers on finger and
thumb, in 22 patients and 22 controls, amplitude decrement
and maximum opening velocity best differentiated between
patients and controls (AUC = 0.87 and 0.81). [16]. Another
study reported significant correlation between infrared mea-
sures of speed and rhythm and clinician rating according
to UPDRS, although these correlation were not very strong
(-0.37 and 0.31) [17].
To our knowledge, only one previous study has used
computer analysis of simple video to detect bradykinesia on
finger tapping [9]. This method tracked index finger motion
and estimated distance by using face height to quantify hand
length (by universal face:hand size ratios, the ‘proportions
of man’). A feature of tapping rhythm, ‘cross-correlation
between the normalized peaks’, showed a strong Guttman
correlation with UPDRS (-0.8), and support vector machine
classification distinguished between PD patients and con-
trols with an accuracy of 95%. However, only 13 patients
participated, and all had advanced Parkinson’s (a disease
stage at which diagnosis is rarely an issue). Furthermore, a
requirement to video the patient’s face could be considered
intrusive, limiting utility in practice.
III. METHOD
A. Data Collection (Video Recording and Clinician Rating)
The study was approved by the UK Health Research
Authority (IRAS no. 224848). Patients with idiopathic PD,
diagnosed by a consultant neurologist at Leeds Teaching
Hospitals NHS Trust, were invited to attend a research clinic
appointment. Control participants were invited from the
partners and companions of patients, or from hospital staff.
Video recordings were made of each hand in turn tapping
forefinger and thumb ‘as quickly and as big as possible’ for
15 seconds. This convenience sample comprised 40 patient
hands and 30 controls hands (20 patient participants and 15
control participants), collected in 2017 and 2018.
The recordings were made using an integrated smartphone
camera (iPhone SE), set to 60 frames per second, 1920x1080
pixels, and placed on a tripod, with only ambient lighting.
The participant was asked to rest their elbow on a chair
arm during the finger tapping and only the hand/forearm
was filmed (no identifiable patient details were filmed). The
distance from camera to hand was not tightly defined; in
practice, the camera was positioned at approximately 1m
from the participant. The lateral (thumb) surface of the hand
faced the camera.
The degree of bradykinesia in each video was indepen-
dently rated by two consultant neurologists with a special
interest in movement on the UPDRS scale [17]. The raters
were blinded to patient/control group. Where there was
disagreement in rater scores, the higher score was used.
B. Data Analysis
1) Data Processing: A schematic of the data processing
framework is presented in Figure 1. Complete details of
the process will be described in future work. An abridged
description now follows.
Initially, the video frames were segmented to pixels
corresponding to a participant’s hand. The hand regions
of interest were first detected using a convolutional neural
network, originally proposed by Bambach et al. [18]. Our
implementation was trained using manual annotation of 500
randomly selected frames from our dataset. A secondary
pixel-level segmentation, the grabcut method [19], was then
used to refine the regions by removing erroneous background
pixels.
The segmented frames were then converted into an optical
flow field [20]. In such a field, each position corresponds to
the vector pixel movement of a point object between two
sequential frames. The magnitude of the vector thus rep-
resents the instantaneous speed of a point (in pixels/frame).
We sum the magnitude at each point in the region of interest
to obtain a metric of overall hand movement.
To convert optical flow magnitude into true hand velocity,
caused by camera distance or hand size (rather than actual
movement), we scale the magnitude by the number of pixels
Figure 1. Illustration of the data processing in which raw video is converted to an anonymous 1D time series. Raw video is first segmented using a
convolutional neural network. The segmentation is refined using the grabcut method. Frame-by-frame movement of the hand is extracted using optical
flow. The optical flow field is then reduced so that the magnitude of movement between two frames is summarized by a single value.
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Figure 2. Examples of the optical flow magnitude time series. Top: no bradykinesia (UPDRS = 0). Bottom: severe bradykinesia (UPDRS = 4).
in the hand region of interest, so that our metric Mt is:
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where H andW are the height and width of the optical flow
field, u and v are the horizontal and vertical components of
the flow, and b is the pixel mask obtained from the image
segmentation. By evaluating Mt over a sequence of video
frames we produce a 1D signal over time. Examples of the
signal are shown in Figure 2.
2) Feature Selection: Candidate features were derived
from the 1D signal via clinical knowledge and visual inspec-
tion. In particular, we derived a set of features that described
the frequency, amplitude, and tap-to-tap variability, to reflect
the UPDRS assessment criteria. The features selected were
as follows.
Frequency: Tapping frequency was estimated as the fre-
quency corresponding to the maximal amplitude peak in the
fast Fourier transform (FFT) spectrum. This assumes that the
finger tapping motion corresponds to the greatest movement
(and thus energy) between frames and that other movements,
such as finger tremor, have smaller magnitude.
Amplitude: Energy spectral density was calculated as the
squared integral of the FFT spectrum. In addition, we
assumed that bradykinesia movement is distinctive in some
frequency bands. Therefore the energy spectral density is
separated into six non-overlapping frequency bands ranging
from 0Hz to 18.36Hz with bandwidth interval 3.06Hz.
Variability: Two variability features were derived using the
peaks of the optical flow waveform. Peaks were calculated
via the MATLAB function findpeaks with zero minimum
peak prominence. Peaks were then classified as maxima or
minima by fitting a 1D Gaussian mixture model with two
clusters to the peak amplitude values. We then defined:
Jitter:We hypothesize that there are differences between the
hand closing and hand opening motions. We further note
that there is an observable difference in higher frequency
movement between maxima and minima. For instance, the
troughs in the signal of the patient in Figure 2 appear subject
to jitter that is not as visible at the peaks. To quantify the
jitter we include the ratio of number of maxima to number
of minima over the entire time series as a predictor.
Peak-to-peak variability: was calculated as the standard
deviation of the time between maxima peaks. This feature
models variation in tapping frequency across the time series
and may be considered analogous to the standard deviation
of RR intervals (SDRR) for ECG signals [21].
C. Classification
We performed binary classification using Naı¨ve Bayes
(NB), logistic regression (LR), and both linear and RBF-
based Support Vector Machines (SVM-L and SVM-R, re-
spectively) [22] to predict two outcomes: 1) a UPDRS score
> 1, and 2) a diagnosis of PD.
Given the relatively small number of samples in the
dataset we reduced the feature space into two dimensions
using principle component analysis. The NB model was
chosen as a simple baseline classifier providing a sensible
lower bound for performance based upon small datasets.
LR provides a linear separation of the data points and this
simplicity may lead to lower generalization error. We incor-
porated ridge (L2) regularization with strength determined
via a grid search to minimize 10-fold cross-validation loss.
The SVM-L model optimizes a different cost function
that the LR model and therefore gives a different linear
separation of the classes. Meanwhile, the SVM-R model
has the ability to model nonlinear decision boundaries. The
slack and (for SVM-R) kernel scaling hyper-parameters were
again estimated using a grid search to minimize 10-fold
cross-validation loss.
We report the accuracy, sensitivity, specificity, and AUC
score for each model. Due to the relatively small size of
our pilot data we estimate the out-of-sample test accuracy
of each model by reporting the mean accuracy of leave-one-
out cross-validation (LOO-CV), with the hyper-parameters
determined via the procedure described above. Analyses
were performed using MATLAB 2017b and the scikit-learn
and Tensorflow packages for Python 3 [23], [24].
IV. RESULTS
A total of 70 videos were collected from 35 participants
(left and right hands), with 40 videos corresponding to the
hands of participants with diagnosed Parkinson’s disease.
UPDRS scores from 0–4 were assigned by two expert
clinicians and then categorized into our binary outcome:
UPDRS ≤ 1 and UPDRS > 1. Their assessment matched in
73% of cases (κ = 0.46). The largest of these two scores
Table I
RESULTS FOR EACH MODEL WHEN PREDICTING WHETHER UPDRS > 1.
THE TEST ACCURACY IS ESTIMATED USING LOO-CV.
Method Accuracy Sensitivity Specificity AUC Test Acc.
NB 0.67 0.76 0.53 0.68 0.64
LR 0.79 0.82 0.75 0.79 0.79
SVM-L 0.79 0.86 0.69 0.79 0.76
SVM-R 0.79 0.86 0.69 0.79 0.76
0.4 0.2 0.0 0.2 0.4
0.2
0.0
0.2
0.4
0.6
UPDRS = (0,1)
UPDRS = (2,3,4)
Figure 3. Decision boundaries for prediction of UPDRS > 1. The
unbroken line is for NB, dashed for SVM-R, dash-dotted for SVM-L, and
dotted for LR.
was selected for training of the models. In Figure 2 we show
an example of UPDRS = 0 and UPDRS = 4 for comparison.
The performance of each model for the prediction of
UPDRS category is shown in Table I. We see that LR and the
two SVMs obtain the best accuracy and AUC scores of 0.79
on the training data, though the SVMs have better sensitivity
with LR obtaining better specificity. NB is not competitive
for this prediction task. The test accuracy (estimated using
LOO-CV) drops to 0.76 for both SVM models, whilst LR
retains its accuracy of 0.79.
In Figure 3 we show each time series plotted in feature-
space after the dimensionality reduction, colored according
to category. We also show the decision boundaries of each
method: an unbroken line for NB, dashed for SVM-R, dash-
dotted for SVM-L, and dotted for LR.
Our second task is the prediction of Parkinson’s disease
itself based upon these features. The performance of each
model for this second task is shown in Table II. SVM-L
obtained the best accuracy of 0.69 and the best specificity
of 0.75. However, the simple NB model obtained the best
sensitivity of 0.81 and AUC score of 0.69. Both LR and
SVM-R were not competitive for this task.
When estimating the test error, the simplicity of the NB
Table II
RESULTS FOR EACH MODEL WHEN PREDICTING PARKINSON’S DISEASE
DIAGNOSIS. THE TEST ACCURACY IS ESTIMATED USING LOO-CV.
Method Accuracy Sensitivity Specificity AUC Test Acc.
NB 0.67 0.81 0.55 0.69 0.63
LR 0.64 0.67 0.75 0.63 0.59
SVM-L 0.69 0.71 0.75 0.68 0.57
SVM-R 0.66 0.75 0.60 0.67 0.57
0.4 0.2 0.0 0.2 0.4
0.2
0.0
0.2
0.4
0.6
Control
Patient
Figure 4. Decision boundaries for prediction of Parkinson’s disease
diagnosis. The unbroken line is for NB, dashed for SVM-R, dash-dotted
for SVM-L, and dotted for LR.
model allowed it to retain an accuracy of 0.63 whilst SVM-
L dropped to 0.57. It appears that, in this relatively small
dataset, SVM-L is highly reliant on a few key data points.
A plot of the time series in feature-space, colored by
category, and the decision boundary of each method is
displayed in Figure 4.
V. DISCUSSION
In a pilot sample of 70 finger-tapping test videos, we
showed reasonable predictive performance for predicting
moderate to severe bradykinesia. The estimated test accuracy
of 0.79 (using LR) is promising in light of the level of
agreement between expert clinical raters (0.73). We also
note that disagreement between the automated method and
clinical experts may be caused when either i) the clinician is
correct and the automated test is wrong, or ii) the clinician
is incorrect and the automated test is right. Given that
prior literature casts doubt on the ability of human experts
to accurately evaluate subtle traits [4], [25], ii) is highly
feasible; such that the reported accuracy may underestimate
how well we truly classify bradykinesia.
The method was less successful at predicting the presence
of Parkinson’s disease diagnosis: NB obtained an estimated
test accuracy of 0.63. This poorer performance is to be
expected, given that bradykinesia is only one symptom of a
more comprehensive clinical diagnosis criteria.
The approach used here has potential to provide widely
available and low-cost bradykinesia detection; without the
requirement for new hardware or for patients to directly
interact with smartphone apps or computer programs. This is
a fundamental difference from previous published methods
to detect or assess bradykinesia [4], [8]. An automated
method broadens access to the measurement of bradykinesia
(currently the preserve of a small group of clinicians, prin-
cipally neurologists). For example, allowing family doctors
and medical nurse practitioners to screen for and monitor the
phenomenon has potential resource benefits. Furthermore,
the use of ubiquitous technology means that the approach
may be suitable in a home setting to monitor progression of
Parkinson’s disease. In addition, it might also be useful for
monitoring other conditions in which there are changes in
movement over time such as rheumatoid arthritis, in which
common symptoms include decreased range of motion and
joint stiffness [26], [27].
Whilst initial results appear promising, our small sample
size means that classification using LR, SVMs, and NB
produced conservative decision boundaries. A large sample
size would allow us to determine whether there was any true
local structure in the feature space.
A larger sample size would also allow us to improve the
usefulness of the system by estimating the UPDRS score
directly, rather than the binary categorization undertaken
here. A larger validation study is therefore necessary and
has been initiated by the study team.
Furthermore, the approach taken here is likely sub-optimal
in two respects. First, spatial and angular information is
discarded at each frame. This has the advantage of reducing
the dimensionality of the signal so that real-time processing,
even on modest hardware, is practicable. Second, the hand-
selection of candidate features was entirely subjective and
may have missed important characteristics in the time series.
Additional data would allow more sophisticated approaches
to automatically learn pertinent features (c.f. [28]).
VI. CONCLUSION AND FUTURE WORK
We have described and demonstrated an automated
method to classify the presence of bradykinesia via smart-
phone video signals. In our small pilot study we have shown
good agreement with expert clinicians. Further improve-
ments may be possible via more sophisticated analyses, but
this required further training data. A larger validation study
of this technology is currently under development.
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